Press Release

Vancouver, British Columbia – October 15, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing [...]

Vancouver, British Columbia – October 8, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing [...]

Vancouver, British Columbia – September 28, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”), an innovative technology company developing products for [...]

Vancouver, British Columbia – August 31, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) an innovative technology company developing products for the [...]

Vancouver, British Columbia – August 12, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing [...]

NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V:NU)(OTCQB:NRXCF), is an innovative technology company developing products for the nutraceutical [...]

VANCOUVER, BC / ACCESSWIRE / July 16, 2020 / NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology [...]

NeutriSci International Inc. (the “Company” or “NeutriSci”) announces that its news release issued on July 3, 2020 with respect to a debt settlement was issued in error [...]

NeutriSci International Inc., an innovative technology company developing products for the nutraceutical industry, announces that it will issue 2,060,534 common shares, at a deemed price of $0.05 [...]

NeutriSci International Inc. (“NeutriSci” or the “Company”) an innovative technology company developing products for the nutraceutical industry, is very pleased to provide [...]